Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Rakovina Therapeutics Inc V.RKV

Alternate Symbol(s):  RKVTF

Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical research company. The Company is focused on the development of new cancer treatments based on novel deoxyribonucleic acid (DNA)-damage response technologies. Its drug development pipeline includes kt-2000AI and kt-3000 series. It is engaged in employing the proprietary Deep Docking AI Platform to rapidly screen billions of potential... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:RKV)

Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas

GlobeNewswire 4 days ago

Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain

GlobeNewswire October 25, 2024

Rakovina Therapeutics Announces Initial Drug Candidates from Deep Docking AI Molecule Discovery Platform

GlobeNewswire October 23, 2024

Rakovina Therapeutics and Variational AI Announce Drug Discovery Collaboration

GlobeNewswire September 17, 2024

Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update

GlobeNewswire August 30, 2024

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

GlobeNewswire July 26, 2024

Rakovina Therapeutics Provides Update on Previously Announced Private Placement

GlobeNewswire July 22, 2024

Rakovina Therapeutics Announces Second Upsizing of Private Placement

GlobeNewswire July 19, 2024

Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting

GlobeNewswire June 20, 2024
View More News ››

Opinion & Analysis (TSXV:RKV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:RKV)

News Update w RKV Executive Chairman Jeffrey Bacha

<< View Post To Watch Video >>
bmreed - October 25, 2024

Webinar Recap w $RKV Executive Chairman Jeffrey Bacha

<< View Post To Watch Video >>
bmreed - October 1, 2024

Webinar $RKV Executive Chair Jeffrey Bacha Sep 24 @ 1PM ET

Live Webinar - Rakovina Therapeutics (RKV) w/ Executive Chairman Jeffrey Bacha Tuesday, September 24th at 1PM ET / 10AM PT Q&A...
bmreed - September 18, 2024

RKV at an offline event

How surprsing is that? I think it is solid info that RKV gonna attend an offline event https://ow.ly/b6wJ50PG2Qh. Its about time we...
sharonw - August 30, 2023

RE:2021 Financial Results/Provides Corporate Update TSXV:RKV

https://www.rakovinatherapeutics.com/
anjz661 - June 15, 2022

2021 Financial Results/Provides Corporate Update TSXV:RKV

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a...
Betteryear2 - April 27, 2022
View more Bullboard ››

GMV Minerals Inc

GMV Minerals Inc

GMV Minerals Inc. is an exploration company focused on developing precious metal assets in Arizona. The Company, through its ...
View More »